226 related articles for article (PubMed ID: 24473850)
1. [Statins and ASS for primary prevention of cardiovascular and cerebrovascular disease].
Goltz L; Bodechtel U; Siepmann T
Dtsch Med Wochenschr; 2014 Feb; 139(6):283-6. PubMed ID: 24473850
[TBL] [Abstract][Full Text] [Related]
2. Use of acetylsalicylic acid by physicians and in the community.
Mahon J; Steel K; Feagan BG; Laupacis A; Pederson LL
CMAJ; 1991 Nov; 145(9):1107-16. PubMed ID: 1751930
[TBL] [Abstract][Full Text] [Related]
3. Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients.
Naderi SH; Bestwick JP; Wald DS
Am J Med; 2012 Sep; 125(9):882-7.e1. PubMed ID: 22748400
[TBL] [Abstract][Full Text] [Related]
4. Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study.
De Socio GV; Ricci E; Parruti G; Calza L; Maggi P; Celesia BM; Orofino G; Madeddu G; Martinelli C; Menzaghi B; Taramasso L; Penco G; Carenzi L; Franzetti M; Bonfanti P
Infection; 2016 Oct; 44(5):589-97. PubMed ID: 27048184
[TBL] [Abstract][Full Text] [Related]
5. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
Hennekens CH; Schneider WR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
[TBL] [Abstract][Full Text] [Related]
6. Continuation of statin therapy and primary prevention of nonfatal cardiovascular events.
Shalev V; Goldshtein I; Porath A; Weitzman D; Shemer J; Chodick G
Am J Cardiol; 2012 Dec; 110(12):1779-86. PubMed ID: 23021514
[TBL] [Abstract][Full Text] [Related]
7. [Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention].
Volpe M; Abrignani MG; Borghi C; Coccheri S; Gresele P; Patti G; Trimarco B; De Caterina R
G Ital Cardiol (Rome); 2014; 15(7-8):442-51. PubMed ID: 25174598
[TBL] [Abstract][Full Text] [Related]
8. [Acetylsalicylic acid in the treatment of cardiovascular and cerebrovascular diseases].
Landmark K
Tidsskr Nor Laegeforen; 1997 Dec; 117(30):4432-6. PubMed ID: 9456592
[TBL] [Abstract][Full Text] [Related]
9. Aspirin in the treatment and prevention of cardiovascular disease: past and current perspectives and future directions.
Hennekens CH; Dalen JE
Am J Med; 2013 May; 126(5):373-8. PubMed ID: 23499330
[TBL] [Abstract][Full Text] [Related]
10. [Statins in primary prophylaxis of cardiovascular diseases].
Kobalava ZhD; Villeval'de SV
Ter Arkh; 2011; 83(9):70-5. PubMed ID: 22145392
[TBL] [Abstract][Full Text] [Related]
11. Statins for primary prevention of cardiovascular disease: the benefits outweigh the risks.
Minder CM; Blumenthal RS; Blaha MJ
Curr Opin Cardiol; 2013 Sep; 28(5):554-60. PubMed ID: 23928920
[TBL] [Abstract][Full Text] [Related]
12. The utility of cardiovascular drugs in the treatment of cerebrovascular disease.
Bösel J; Amiri H
Curr Opin Investig Drugs; 2010 Sep; 11(9):1015-24. PubMed ID: 20730696
[TBL] [Abstract][Full Text] [Related]
13. [Statins with a perspective of lifelong therapy].
Ertaş FS
Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():29-36. PubMed ID: 19404048
[TBL] [Abstract][Full Text] [Related]
14. Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for a friendly use.
Maggi P; De Socio GV; Cicalini S; D'Abbraccio M; Dettorre G; Di Biagio A; Martinelli C; Nunnari G; Rusconi S; Sighinolfi L; Spagnuolo V; Squillace N
AIDS Res Ther; 2019 May; 16(1):11. PubMed ID: 31126301
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol, cholesterol-lowering agents/statins, and urologic disease: Part V--Statins versus aspirin for primary prevention, and the winner is...?
Moyad MA; Merrick GS
Urol Nurs; 2007 Apr; 27(2):166-8. PubMed ID: 17494461
[TBL] [Abstract][Full Text] [Related]
16. Compliance with cardiovascular drug prevention measures in a general population: the Multidisciplinary Intervention in Primary Care (IMAP) study.
Lopez-Carmona D; Bernal-Lopez M; Mancera-Romero J; Jansen-Chaparro S; Portales-Fernandez I; Baca-Osorio AJ; Perez-Gonzalez R; Tinahones FJ; Gomez-Huelgas R
Eur J Prev Cardiol; 2012 Oct; 19(5):1074-81. PubMed ID: 21810843
[TBL] [Abstract][Full Text] [Related]
17. Statins for primary prevention of cardiovascular and cerebrovascular events in diabetic patients without established cardiovascular diseases: a meta-analysis.
Chen YH; Feng B; Chen ZW
Exp Clin Endocrinol Diabetes; 2012 Feb; 120(2):116-20. PubMed ID: 22187291
[TBL] [Abstract][Full Text] [Related]
18. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
19. Statins and stroke prevention.
Paciaroni M; Hennerici M; Agnelli G; Bogousslavsky J
Cerebrovasc Dis; 2007; 24(2-3):170-82. PubMed ID: 17596685
[TBL] [Abstract][Full Text] [Related]
20. [Acetylsalicylic acid in primary prevention of cardiovascular events; literature study].
Bredie SJ; Wollersheim HC; Verheugt FW; Thien T
Ned Tijdschr Geneeskd; 2002 Jan; 146(2):68-72. PubMed ID: 11820060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
